Base to Base biotech podcast 31: Exhilarating enzymes and super socks
New company to develop psoriasis monoclonal antibody
DNA nanospring could boost disease diagnosis
Health Canada approves first treatment for Duchenne muscular dystrophy
FDA grants orphan drug designation to gene therapy for ALS
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Arcus Biosciences receives Orphan Drug Designation for pancreatic cancer treatment
IGI and AbbVie announce exclusive global licensing agreement for trispecific antibody
Angelman syndrome results published
Champions Oncology launches radiopharmaceutical services platform
Partnership created scale up cell-based mRNA design and manufacturing platform
New drug target for treating cancer and viral infections